Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06697886 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold

StatusRecruiting
PhasePhase 3
Started2023-11-16
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 20, 2024 (before its estimated June 25, 2025 completion). Its status may not reflect the trial's current state.
To further evaluate the efficacy and safety of Antiwei granule in the treatment of common cold (wind-cold syndrome)
Trial Details
NCT Number NCT06697886
Lead Sponsor Tasly Pharmaceutical Group Co., Ltd
Conditions Common Cold
Enrollment 480 participants
Start Date 2023-11-16
Primary Completion 2025-06-25 (estimated)
Study Completion 2025-07-01 (estimated)
Updated on ClinicalTrials.gov 2024-11-20